Patents by Inventor Patrick Emond

Patrick Emond has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RADIOLABELLED COMPOUNDS FOR DIAGNOSING CHOLINERGIC NEURODEGENERATIVE DISEASES
    Publication number: 20240058481
    Abstract: The present invention relates to the radiolabelled compound of enantiomer (R,R) of 5-fluoro-3-4(-phenylpiperidin-1-yl)-1,2,3,4-tetrahydronaphthalen-2-ol, and to this compound for use thereof in an in vivo diagnosis method, in particular of a cholinergic neurodegenerative disease selected for example from the group formed by Alzheimer's disease, dysmnesia, learning disability, schizophrenia, cognitive dysfunction, hyperactivity disorder, anxiety neurosis, depression, analgesia and Parkinson's disease.
    Type: Application
    Filed: November 23, 2021
    Publication date: February 22, 2024
    Inventors: Sylvain ROUTIER, Frédéric BURON, Franck SUZENET, Nuno RODRIGUES, Sylvie CHALON, Johnny VERCOUILLIE, Denis GUILLOTEAU, Patrick EMOND, Hamid MARZAG
  • Tropane derivatives useable in particular for in vivo detection of dopamine transporters
    Patent number: 6180083
    Abstract: The present invention relates to tropane derivatives having particular use for the in vivo detection of dopamine transporters. These derivatives meet the formula in which R1 is I or Sn (R3)3, R2 is for example the methyl group, and X and Y are various substituents. The derivatives with X═CH3 and Y═H show strong specificity for the dopamine transporter compared with the serotonin transporter (74% inhibition when the transporter is previously saturated with GBR 12909).
    Type: Grant
    Filed: November 10, 1998
    Date of Patent: January 30, 2001
    Assignee: CIS bio International
    Inventors: Laurent Mauclaire, Patrick Emond, Denis Guilloteau, Jean-Claude Besnard, Yves Frangin